<!DOCTYPE html PUBLIC "-//W3C//DTD HTML 4.01//EN" "http://www.w3.org/TR/html4/strict.dtd">
<html xmlns:n1="urn:hl7-org:v3" xmlns:in="urn:lantana-com:inline-variable-data" xmlns:sdtc="urn:hl7-org:sdtc"><head>
<meta charset="utf-8"><!-- Do NOT edit this HTML directly: it was generated via an XSLT transformation from a CDA Release 2 XML document. --><title>Progress note - 07/10/2024</title><style type="text/css">
body {
  color: #003366;
  background-color: #FFFFFF;
  font-family: Verdana, Tahoma, sans-serif;
  font-size: 14px;
}

a {
  color: #003366;
  background-color: #FFFFFF;
}

h1 {
  font-size: 20px;
  font-weight: bold;
}

h2 {
  font-size: 18px;
  font-weight: bold;
}

h3 {
  font-size: 14px;
  font-weight: bold;
}

h4 {
  font-size: 14px;
  font-weight: bold;
}


table {
  width: 100%;
}

th {
  background-color: #ffd700;
}

td {
  padding: 0.1cm 0.2cm;
  vertical-align: top;
  background-color: #ffffcc;
}

.h1center {
  font-size: 20px;
  font-weight: bold;
  text-align: center;
  width: 80%;
}

.header_table{
  border: 1pt inset #00008b;
}

.td_label{
  font-weight: bold;
  color: white;
}

.content_span{
 font-family: Verdana, Tahoma, sans-serif;
 display: inline;
 white-space: pre-line;
}

.td_header_role_name{
  width: 20%;
  background-color: #3399ff;
}

.td_header_role_value{
  width: 80%;
  background-color: #ccccff;
}

.Bold{
  font-weight: bold;
}

.Italics{
  font-style: italic;
}

.Underline{
  text-decoration:underline;
}

.internal_format
{
	list-style: none;
	list-style-position:outside;
	margin:0;
	padding:0;
	border:0;
	border-collapse: collapse;
}
          </style></head><body><h1 class="h1center">Progress note - 07/10/2024</h1><table class="header_table"><tr><td class="td_header_role_name"><span class="td_label">Patient</span></td><td class="td_header_role_value">Patrick L Buttil</td></tr><tr><td class="td_header_role_name"><span class="td_label">Date of birth</span></td><td class="td_header_role_value">October 7, 1954 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Current Gender</span></td><td class="td_header_role_value">Male</td></tr><tr><td class="td_header_role_name"><span class="td_label">Race(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>White</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Ethnicity</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>Not Hispanic or Latino</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Language(s)</span></td><td class="td_header_role_value"><ul style="list-style: none;list-style-position:outside;margin:0;padding:0; "><li>English (Preferred)</li></ul></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"> Postal Address:<br/>3787 PALACE DR<br/>PALM HARBOR, FL 34684-4146, US<br/><br/>Primary Home Phone:  727-514-2936<br/>Email:  PBUTTIL70@GMAIL.COM<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Patient IDs</span></td><td class="td_header_role_value">17625 2.16.840.1.113883.4.391.327187<br/>17625 2.16.840.1.113883.4.391.327187.1<br/></td></tr></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document Id</span></td><td class="td_header_role_value">b6873708-2eb6-425c-bd4a-744dba9e10bf 2.16.840.1.113883.4.391</td></tr><tr><td class="td_header_role_name"><span class="td_label">Document Created:</span></td><td class="td_header_role_value">September 11, 2024, 17:57:44 -0400 </td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Performer (primary care physician)</span></td><td class="td_header_role_value"><table class="header_table internal_format"><tbody><tr><td class="td_header_role_value internal_format">Santiago Morales</td></tr><tr><td class="td_header_role_value internal_format">34650 US HIGHWAY 19 N<br/>STE 104<br/>PALM HARBOR, FL 34684-2155, US<br/><br/>Tel:  727-233-4895<br/></td></tr></tbody></table></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Author</span></td><td class="td_header_role_value">eClinicalWorks</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/><br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Encounter Id</span></td><td class="td_header_role_value">20766417 2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Type</span></td><td class="td_header_role_value">ambulatory</td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Date</span></td><td class="td_header_role_value"> From July 10, 2024, 11:00:00   to July 10, 2024, 11:20:00  </td></tr><tr><td class="td_header_role_name"><span class="td_label">Encounter Location</span></td><td class="td_header_role_value">id:  2.16.840.1.113883.4.391.327187</td></tr><tr><td class="td_header_role_name"><span class="td_label">Responsible party</span></td><td class="td_header_role_value">Santiago Morales</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">34650 US HIGHWAY 19 N<br/>STE 104<br/>PALM HARBOR, FL 34684-2155, US<br/><br/>Tel:  727-233-4895<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Emergency contact</span></td><td class="td_header_role_value">Leiganne ely<br/><br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">3787 PALACE DR<br/>PALM HARBOR, FL 34684-4146, US<br/><br/>Tel:  727-534-1800<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Guarantor</span></td><td class="td_header_role_value">Patrick Buttil<br/></td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value"><br/><br/>Tel:  727-514-2936<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Legal authenticator</span></td><td class="td_header_role_value">Santiago Morales signed at July 10, 2024 </td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">34650 US HIGHWAY 19 N<br/>STE 104<br/>PALM HARBOR, FL 34684-2155, US<br/><br/>Tel:  727-233-4895<br/></td></tr></tbody></table><table class="header_table"><tbody><tr><td class="td_header_role_name"><span class="td_label">Document maintained by</span></td><td class="td_header_role_value">MyCare Medical Group</td></tr><tr><td class="td_header_role_name"><span class="td_label">Contact info</span></td><td class="td_header_role_value">1785 NORTHPOINTE PKWY<br/>STE 300<br/>LUTZ, FL 33558-5742, US<br/><br/>Tel:  813-536-7277<br/></td></tr></tbody></table><h2><a name="toc">Table of Contents</a></h2><ul><li><a href="#id1">Allergies</a></li><li><a href="#id2">REASON FOR VISIT</a></li><li><a href="#id3">Medications</a></li><li><a href="#id4">Social History</a></li><li><a href="#id5">Vital Signs</a></li><li><a href="#id6">Encounters</a></li><li><a href="#id7">Assessments</a></li><li><a href="#id8">Plan Of Treatment</a></li><li><a href="#id9">Progress Notes</a></li><li><a href="#id10">History and Physical Notes</a></li></ul><hr align="left" color="teal" size="2"/><h3><a name="id1" href="#toc">Allergies</a></h3><div><span class="content_span">No Known Allergies</span></div><h3><a name="id2" href="#toc">REASON FOR VISIT</a></h3><div>monthly f/u, stool occult needed</div><h3><a name="id3" href="#toc">Medications</a></h3><div><table width="100%" border="1"><thead><tr><th>Medication</th><th>SIG (Take, Route, Frequency, Duration)</th><th>Notes</th><th>Start Date</th><th>End Date</th><th>Status</th></tr></thead><tbody><tr><td ID="medication1">Aspirin 81 81 MG</td><td ID="instruction1">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication2">Fenofibrate 160 MG</td><td ID="instruction2">1 tablet Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication3">Isosorbide Mononitrate ER 30 MG</td><td ID="instruction3">1 tablet in the morning Orally Once a day for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication4">Budesonide-Formoterol Fumarate 80-4.5 MCG/ACT</td><td ID="instruction4">2 puffs Inhalation Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication5">Clopidogrel Bisulfate 75 MG</td><td ID="instruction5">TAKE 1 TABLET DAILY for 90</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication6">Carvedilol 12.5 MG</td><td ID="instruction6">1 tablet with food Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication7">metFORMIN HCl 500 MG</td><td ID="instruction7">TAKE 2 TABLETS TWICE A DAY WITH MEALS Orally Twice a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication8">Lantus 100 UNIT/ML</td><td ID="instruction8">40 units Subcutaneous daily</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication9">Atorvastatin Calcium 80 MG</td><td ID="instruction9">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication10">Furosemide 40 MG</td><td ID="instruction10">TAKE 1 TABLET ONCE DAILY</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication11">Lisinopril 10 MG</td><td ID="instruction11">TAKE 1 TABLET TWICE A DAY Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication12">NovoLOG PenFill 100 UNIT/ML</td><td ID="instruction12">20 UNITS Subcutaneous DAILY BEFORE MEAL</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication13">Ipratropium-Albuterol 0.5-2.5 (3) MG/3ML</td><td ID="instruction13">3 mL as needed Inhalation every 6 hrs for 90 days</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication14">Xarelto 10 MG</td><td ID="instruction14"><p>1 tablet Orally Once a day</p><p>Duration: 6 weeks</p></td><td ID="medication14notes">Duration: 6 weeks</td><td/><td/><td>Active</td></tr><tr><td ID="medication15">Pen Needles 32G X 4 MM</td><td ID="instruction15">as directed sub q four times a day for 90 days</td><td/><td>08/03/2021</td><td/><td>Active</td></tr><tr><td ID="medication16">Vitamin B12</td><td ID="instruction16"/><td ID="medication16notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Active</td></tr><tr><td ID="medication17">Lancets 28G -</td><td ID="instruction17">as directed vitro daily for 90 days</td><td/><td>04/16/2020</td><td/><td>Active</td></tr><tr><td ID="medication18">FORA D10 2-in-1 Monitor -</td><td ID="instruction18">as directed invitro testing bid for 90 days</td><td/><td>04/16/2020</td><td/><td>Active</td></tr><tr><td ID="medication19">FORA Blood Glucose Test -</td><td ID="instruction19">as directed In Vitro daily for 90 days</td><td/><td>04/16/2020</td><td/><td>Active</td></tr><tr><td ID="medication20">Vitamin D</td><td ID="instruction20"/><td ID="medication20notes">*Pick strength-form from Medispan for eRX*</td><td/><td/><td>Active</td></tr><tr><td ID="medication21">NovoLOG FlexPen 100 UNIT/ML</td><td ID="instruction21">15-20 units Subcutaneous Three times a day before meals</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication22">Nitroglycerin 0.4 MG</td><td ID="instruction22">as directed Sublingual</td><td ID="medication22notes">PRN</td><td/><td/><td>Active</td></tr><tr><td ID="medication23">glipiZIDE 10 MG</td><td ID="instruction23">1 tablet 30 minutes before breakfast Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication24">Insulin Aspart PenFill 100 UNIT/ML</td><td ID="instruction24">as directed Subcutaneous 20 units per day before meal for 90 days</td><td ID="medication24notes">Before mailing prescription call patient and advise, thank you</td><td>05/19/2023</td><td/><td>Active</td></tr><tr><td ID="medication25">Ezetimibe 10 MG</td><td ID="instruction25">1 tablet Orally Once a day</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication26">Ergocalciferol 1.25 MG (50000 UT)</td><td ID="instruction26">1 capsule Orally every Friday</td><td/><td/><td/><td>Active</td></tr><tr><td ID="medication27">Cyanocobalamin 1000 MCG/ML</td><td ID="instruction27">1 mL Injection Once a month, 25th of each month</td><td/><td/><td/><td>Active</td></tr></tbody></table></div><h3><a name="id4" href="#toc">Social History</a></h3><div><span class="content_span">Sex Assigned At Birth:</span><table width="100%" border="1"><thead><tr><th>Social History Observation</th><th>Description</th></tr></thead><tbody><tr><td ID="BirthSexInfo">Sex Assigned At Birth</td><td>Male</td></tr></tbody></table></div><h3><a name="id5" href="#toc">Vital Signs</a></h3><div><table width="100%" border="1"><tbody><tr><th ID="vital1">Temperature</th><td>97.9 degrees Fahrenheit</td><td>07/10/2024</td></tr><tr><th ID="vital2">Blood pressure systolic</th><td>107 mm Hg</td><td>07/10/2024</td></tr><tr><th ID="vital3">Blood pressure diastolic</th><td>67 mm Hg</td><td>07/10/2024</td></tr><tr><th ID="vital4">Heart Rate</th><td>67 /min</td><td>07/10/2024</td></tr><tr><th ID="vital5">Respiratory Rate</th><td>16 /min</td><td>07/10/2024</td></tr><tr><th ID="vital6">Height</th><td>72 in</td><td>07/10/2024</td></tr><tr><th ID="vital7">Weight</th><td>177 lbs</td><td>07/10/2024</td></tr><tr><th ID="vital8">BMI</th><td>24 kg/m2</td><td>07/10/2024</td></tr><tr><th ID="vital9">Oximetry</th><td>98 %</td><td>07/10/2024</td></tr><tr><th ID="vital10">Height-cm</th><td>182.88 cm</td><td>07/10/2024</td></tr><tr><th ID="vital11">Weight-kg</th><td>80.29 kg</td><td>07/10/2024</td></tr><tr><td colspan="3"><span class="content_span">yr</span></td></tr></tbody></table></div><h3><a name="id6" href="#toc">Encounters</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter</th><th>Location</th><th>Date</th><th>Provider</th><th>Diagnosis</th></tr></thead><tbody><tr><td>MCM Palm Harbor</td><td>34650 US HIGHWAY 19 N STE 104 PALM HARBOR, FL 34684-2155</td><td>07/10/2024</td><td>Santiago Morales</td><td>TYPE 2 DIABETES MELLITUS E11.9 ; S/P total right hip arthroplasty Z96.641 ; Type 2 diabetes mellitus with other specified complication E11.69 ; Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease I13.0 ; Mixed hyperlipidemia E78.2 ; Presence of cardiac pacemaker Z95.0 ; Sick sinus syndrome I49.5 ; Chronic systolic CHF (congestive heart failure) I50.22 ; Long term (current) use of insulin Z79.4 and Type 2 diabetes mellitus with diabetic chronic kidney disease E11.22</td></tr></tbody></table></div><h3><a name="id7" href="#toc">Assessments</a></h3><div><table width="100%" border="1"><thead><tr><th>Encounter Date</th><th>Diagnosis (ICD Code)</th><th>Assessment Notes</th><th>Treatment Notes</th><th>Treatment Clinical Notes</th></tr></thead><tbody><tr><td ID="ref1">07/10/2024</td><td>TYPE 2 DIABETES MELLITUS (ICD-10 - E11.9)</td><td/><td>Diabetic meds as noted </td><td/></tr><tr><td ID="ref2">07/10/2024</td><td>S/P total right hip arthroplasty (ICD-10 - Z96.641)</td><td/><td>Stable </td><td/></tr><tr><td ID="ref3">07/10/2024</td><td>Type 2 diabetes mellitus with other specified complication (ICD-10 - E11.69)</td><td>associated with hyperlipidemia</td><td>patient advised to follow lowfat low-cholesterol diet</td><td/></tr><tr><td ID="ref4">07/10/2024</td><td>Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease (ICD-10 - I13.0)</td><td/><td/><td/></tr><tr><td ID="ref5">07/10/2024</td><td>Mixed hyperlipidemia (ICD-10 - E78.2)</td><td/><td/><td/></tr><tr><td ID="ref6">07/10/2024</td><td>Presence of cardiac pacemaker (ICD-10 - Z95.0)</td><td/><td>stable continue follow up with cardiology for pacemaker checks</td><td/></tr><tr><td ID="ref7">07/10/2024</td><td>Sick sinus syndrome (ICD-10 - I49.5)</td><td/><td>stable after pacemaker placement</td><td/></tr><tr><td ID="ref8">07/10/2024</td><td>Chronic systolic CHF (congestive heart failure) (ICD-10 - I50.22)</td><td/><td/><td/></tr><tr><td ID="ref9">07/10/2024</td><td>Long term (current) use of insulin (ICD-10 - Z79.4)</td><td/><td>Stable </td><td/></tr><tr><td ID="ref10">07/10/2024</td><td>Type 2 diabetes mellitus with diabetic chronic kidney disease (ICD-10 - E11.22)</td><td/><td/><td/></tr></tbody></table></div><h3><a name="id8" href="#toc">Plan Of Treatment</a></h3><div><span class="content_span">Medication</span><table width="100%" border="1"><thead><tr><th>Medication Name</th><th>Sig</th><th>Start Date</th><th>Stop Date</th><th>Notes</th></tr></thead><tbody><tr><td ID="potMeds1">Fenofibrate 160 MG</td><td>1 tablet Orally Once a day for 90 days</td><td/><td/><td/></tr><tr><td ID="potMeds2">Carvedilol 12.5 MG</td><td>1 tablet with food Orally Twice a day</td><td/><td/><td/></tr><tr><td ID="potMeds3">metFORMIN HCl 500 MG</td><td>TAKE 2 TABLETS TWICE A DAY WITH MEALS Orally Twice a day</td><td/><td/><td/></tr><tr><td ID="potMeds4">Lantus 100 UNIT/ML</td><td>40 units Subcutaneous daily</td><td/><td/><td/></tr><tr><td ID="potMeds5">Atorvastatin Calcium 80 MG</td><td>1 tablet Orally Once a day</td><td/><td/><td/></tr><tr><td ID="potMeds6">Furosemide 40 MG</td><td>TAKE 1 TABLET ONCE DAILY</td><td/><td/><td/></tr><tr><td ID="potMeds7">Lisinopril 10 MG</td><td>TAKE 1 TABLET TWICE A DAY Orally Once a day</td><td/><td/><td/></tr><tr><td ID="potMeds8">NovoLOG PenFill 100 UNIT/ML</td><td>20 UNITS Subcutaneous DAILY BEFORE MEAL</td><td/><td/><td/></tr></tbody></table><span class="content_span">Treatment Notes</span><table width="100%" border="1"><thead><tr><th>Assessment</th><th>Notes</th></tr></thead><tbody><tr><td ID="instructionpot1">TYPE 2 DIABETES MELLITUS</td><td>Diabetic meds as noted </td></tr><tr><td ID="instructionpot2">S/P total right hip arthroplasty</td><td>Stable </td></tr><tr><td ID="instructionpot3">Type 2 diabetes mellitus with other specified complication</td><td>patient advised to follow lowfat low-cholesterol diet</td></tr><tr><td ID="instructionpot4">Presence of cardiac pacemaker</td><td>stable continue follow up with cardiology for pacemaker checks</td></tr><tr><td ID="instructionpot5">Sick sinus syndrome</td><td>stable after pacemaker placement</td></tr><tr><td ID="instructionpot6">Long term (current) use of insulin</td><td>Stable </td></tr></tbody></table><span class="content_span">Next Appt</span><table width="100%" border="1"><thead><tr><th>Details</th></tr></thead><tbody><tr><td ID="nextAppt">Follow Up: 4 Months, Reason: </td></tr><tr><td ID="futureAppt1">Provider Name:Santiago D Morales, 11/04/2024 08:30:00 AM, 34650 US HIGHWAY 19 N, STE 104, PALM HARBOR, FL, 34684-2155, 727-233-4895</td></tr><tr><td ID="futureAppt2">Provider Name:Santiago D Morales, 11/11/2024 11:15:00 AM, 34650 US HIGHWAY 19 N, STE 104, PALM HARBOR, FL, 34684-2155, 727-233-4895</td></tr></tbody></table></div><h3><a name="id9" href="#toc">Progress Notes</a></h3><div><ul><li><table width="99%" border="0" cellspacing="0" cellpadding="0"><thead><tr><td><content>BUTTIL, Patrick L <span class="bold">DOB:</span> 10/07/1954 (69 yo M) <span class="bold">Acc No.</span> 17625 <span class="bold">DOS:</span> 07/10/2024</content></td></tr></thead><tbody><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td align="right" colspan="2"><span class="bold"/></td></tr><tr><td align="left"><span class="bold">Patient: </span>BUTTIL, Patrick L<br/><span class="bold">Account Number: </span>17625</td><td align="right"><span class="bold">Provider: </span>Santiago Morales, MD</td></tr><tr><td align="left"/></tr><tr><td align="left"><span class="bold">DOB: </span>10/07/1954<span class="bold">   Age: </span>69 Y<span class="bold">   Sex: </span>Male</td><td align="right"><span class="bold">Date: </span>07/10/2024</td></tr><tr><td><span class="bold">Phone: </span>727-514-2936</td></tr><tr><td colspan="2"><span class="bold">Address: </span>3787 PALACE DR, PALM HARBOR, FL-34684-4146</td></tr></tbody></table></li></ul><br/><content><span class="bold">Subjective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Chief Complaints:</span></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td>   Monthly f/uStool occult needed</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">HPI: </span><br/>   <span class="Underline">Routine F/U</span>: <br/>       Patient here for routine follow-up no new complaints denies any chest pain shortness of breath or diaphoresis appetite is good bowel movements normal joints are fine.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">ROS:</span> <br/>   ROS: Unremarkable except as noted in the HPI.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medical History:</span> </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Surgical History:</span> eye surgery Pace maker 2013</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Hospitalization/Major Diagnostic Procedure:</span> Denies Past Hospitalization</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Family History:</span> Father: deceased. Mother: deceased. 2 daughter(s)  - healthy. . </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Social History:</span> <br/>   quit 3/13/24 <br/>50 pk/yr.</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Medications:</span> TakingLisinopril 10 MG Tablet TAKE 1 TABLET TWICE A DAY Orally Once a day NovoLOG PenFill 100 UNIT/ML Solution Cartridge 20 UNITS Subcutaneous DAILY BEFORE MEAL Carvedilol 12.5 MG Tablet 1 tablet with food Orally Twice a day Lantus 100 UNIT/ML Solution 40 units Subcutaneous daily metFORMIN HCl 500 MG Tablet TAKE 2 TABLETS TWICE A DAY WITH MEALS Orally Twice a day Furosemide 40 MG Tablet TAKE 1 TABLET ONCE DAILY   Atorvastatin Calcium 80 MG Tablet 1 tablet Orally Once a day Fenofibrate 160 MG Tablet 1 tablet Orally Once a day Budesonide-Formoterol Fumarate 80-4.5 MCG/ACT Aerosol 2 puffs Inhalation Twice a day Isosorbide Mononitrate ER 30 MG Tablet Extended Release 24 Hour 1 tablet in the morning Orally Once a day Aspirin 81 81 MG Tablet Delayed Release 1 tablet Orally Once a day Clopidogrel Bisulfate 75 MG Tablet TAKE 1 TABLET DAILY   Cyanocobalamin 1000 MCG/ML Solution 1 mL Injection Once a month, 25th of each month Ergocalciferol 1.25 MG (50000 UT) Capsule 1 capsule Orally every Friday Ezetimibe 10 MG Tablet 1 tablet Orally Once a day glipiZIDE 10 MG Tablet 1 tablet 30 minutes before breakfast Orally Once a day Insulin Aspart PenFill 100 UNIT/ML Solution Cartridge as directed Subcutaneous 20 units per day before meal , Notes to Pharmacist: Before mailing prescription call patient and advise, thank youNitroglycerin 0.4 MG Tablet Sublingual as directed Sublingual  , Notes to Pharmacist: PRNNovoLOG FlexPen 100 UNIT/ML Solution Pen-injector 15-20 units Subcutaneous Three times a day before meals FORA Blood Glucose Test - Strip as directed In Vitro daily FORA D10 2-in-1 Monitor - Device as directed invitro testing bid Lancets 28G - Miscellaneous as directed vitro daily Vitamin B12      , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Vitamin D      , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Pen Needles 32G X 4 MM Miscellaneous as directed sub q four times a day Xarelto 10 MG Tablet 1 tablet Orally Once a day Duration: 6 weeks, Notes to Pharmacist: Duration: 6 weeksIpratropium-Albuterol 0.5-2.5 (3) MG/3ML Solution 3 mL as needed Inhalation every 6 hrs Medication List reviewed and reconciled with the patientTaking Lisinopril 10 MG Tablet TAKE 1 TABLET TWICE A DAY Orally Once a day Taking NovoLOG PenFill 100 UNIT/ML Solution Cartridge 20 UNITS Subcutaneous DAILY BEFORE MEAL Taking Carvedilol 12.5 MG Tablet 1 tablet with food Orally Twice a day Taking Lantus 100 UNIT/ML Solution 40 units Subcutaneous daily Taking metFORMIN HCl 500 MG Tablet TAKE 2 TABLETS TWICE A DAY WITH MEALS Orally Twice a day Taking Furosemide 40 MG Tablet TAKE 1 TABLET ONCE DAILY   Taking Atorvastatin Calcium 80 MG Tablet 1 tablet Orally Once a day Taking Fenofibrate 160 MG Tablet 1 tablet Orally Once a day Taking Budesonide-Formoterol Fumarate 80-4.5 MCG/ACT Aerosol 2 puffs Inhalation Twice a day Taking Isosorbide Mononitrate ER 30 MG Tablet Extended Release 24 Hour 1 tablet in the morning Orally Once a day Taking Aspirin 81 81 MG Tablet Delayed Release 1 tablet Orally Once a day Taking Clopidogrel Bisulfate 75 MG Tablet TAKE 1 TABLET DAILY   Taking Cyanocobalamin 1000 MCG/ML Solution 1 mL Injection Once a month, 25th of each month Taking Ergocalciferol 1.25 MG (50000 UT) Capsule 1 capsule Orally every Friday Taking Ezetimibe 10 MG Tablet 1 tablet Orally Once a day Taking glipiZIDE 10 MG Tablet 1 tablet 30 minutes before breakfast Orally Once a day Taking Insulin Aspart PenFill 100 UNIT/ML Solution Cartridge as directed Subcutaneous 20 units per day before meal , Notes to Pharmacist: Before mailing prescription call patient and advise, thank youTaking Nitroglycerin 0.4 MG Tablet Sublingual as directed Sublingual  , Notes to Pharmacist: PRNTaking NovoLOG FlexPen 100 UNIT/ML Solution Pen-injector 15-20 units Subcutaneous Three times a day before meals Taking FORA Blood Glucose Test - Strip as directed In Vitro daily Taking FORA D10 2-in-1 Monitor - Device as directed invitro testing bid Taking Lancets 28G - Miscellaneous as directed vitro daily Taking Vitamin B12      , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Taking Vitamin D      , Notes to Pharmacist: *Pick strength-form from Medispan for eRX*Taking Pen Needles 32G X 4 MM Miscellaneous as directed sub q four times a day Taking Xarelto 10 MG Tablet 1 tablet Orally Once a day Duration: 6 weeks, Notes to Pharmacist: Duration: 6 weeksTaking Ipratropium-Albuterol 0.5-2.5 (3) MG/3ML Solution 3 mL as needed Inhalation every 6 hrs Medication List reviewed and reconciled with the patient</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Allergies:</span> N.K.D.A.no[Allergies Verified]</td></tr></tbody></table></li></ul><br/><content><span class="bold">Objective:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Vitals:</span> Ht: 72 in, Wt: <span class="bold">177</span> lbs, Wt-kg: 80.29 kg, BMI: <span class="bold">24</span> Index, BP: <span class="bold">107/67</span> mm Hg, HR: <span class="bold">67</span> /min, Temp: <span class="bold">97.9</span> F, RR: <span class="bold">16</span> /min, Oxygen sat %: <span class="bold">98</span> %, Pain scale: <span class="bold">0</span> 1-10, Body Surface Area: 2.02, Ht-cm: 182.88 cm.<br/>yr.</td></tr></tbody></table></li></ul><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td><span class="bold">   Past Orders:</span></td></tr><tr><td colspan="4"><ul><li><table width="100%"><tbody><tr><td><ul><li><table border="1"><tbody><tr><td colspan="4"><content class="Underline"><span class="bold">Lab:CBC With Differential/Platelet-005009</span></content></td></tr></tbody></table></li></ul><ul><li><table frame="void" rules="rows" cellpadding="0" cellspacing="0" border="1" width="100%"><tbody><tr><td align="left">Collection Date</td><td align="left">06/04/2024</td><td align="left">04/15/2024</td><td align="left">02/23/2024</td><td align="left">01/25/2024</td><td align="left">07/24/2023</td></tr><tr><td align="left">Collection Time</td><td align="left">06:43 AM</td><td align="left">07:20 AM</td><td align="left">07:34 AM</td><td align="left">07:00 AM</td><td align="left"/></tr><tr><td align="left">Order Date</td><td align="left">06/04/2024</td><td align="left">03/15/2024</td><td align="left">02/29/2024</td><td align="left">01/05/2024</td><td align="left">07/24/2023</td></tr><tr><td align="left">WBC</td><td align="left">10.5<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">9.8<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">8.6<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">7.9<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td><td align="left">10.3<br/>(Ref Range: 3.4-10.8 x10E3/uL)</td></tr><tr><td align="left">RBC</td><td class="bold" align="left">4.02    L<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td class="bold" align="left">3.62    L<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td class="bold" align="left">3.47    L<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td class="bold" align="left">3.00    L<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td><td align="left">4.29<br/>(Ref Range: 4.14-5.80 x10E6/uL)</td></tr><tr><td align="left">Hemoglobin</td><td class="bold" align="left">11.3    L<br/>(Ref Range: 13.0-17.7 g/dL)</td><td class="bold" align="left">10.1    L<br/>(Ref Range: 13.0-17.7 g/dL)</td><td class="bold" align="left">9.8    L<br/>(Ref Range: 13.0-17.7 g/dL)</td><td class="bold" align="left">8.4    L<br/>(Ref Range: 13.0-17.7 g/dL)</td><td class="bold" align="left">12.7    L<br/>(Ref Range: 13.0-17.7 g/dL)</td></tr><tr><td align="left">Hematocrit</td><td class="bold" align="left">35.0    L<br/>(Ref Range: 37.5-51.0 %)</td><td class="bold" align="left">31.2    L<br/>(Ref Range: 37.5-51.0 %)</td><td class="bold" align="left">30.2    L<br/>(Ref Range: 37.5-51.0 %)</td><td class="bold" align="left">26.9    L<br/>(Ref Range: 37.5-51.0 %)</td><td class="bold" align="left">36.8    L<br/>(Ref Range: 37.5-51.0 %)</td></tr><tr><td align="left">MCV</td><td align="left">87<br/>(Ref Range: 79-97 fL)</td><td align="left">86<br/>(Ref Range: 79-97 fL)</td><td align="left">87<br/>(Ref Range: 79-97 fL)</td><td align="left">90<br/>(Ref Range: 79-97 fL)</td><td align="left">86<br/>(Ref Range: 79-97 fL)</td></tr><tr><td align="left">MCH</td><td align="left">28.1<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">27.9<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">28.2<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">28.0<br/>(Ref Range: 26.6-33.0 pg)</td><td align="left">29.6<br/>(Ref Range: 26.6-33.0 pg)</td></tr><tr><td align="left">MCHC</td><td align="left">32.3<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">32.4<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">32.5<br/>(Ref Range: 31.5-35.7 g/dL)</td><td class="bold" align="left">31.2    L<br/>(Ref Range: 31.5-35.7 g/dL)</td><td align="left">34.5<br/>(Ref Range: 31.5-35.7 g/dL)</td></tr><tr><td align="left">RDW</td><td align="left">14.6<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">14.4<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.4<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">14.3<br/>(Ref Range: 11.6-15.4 %)</td><td align="left">13.0<br/>(Ref Range: 11.6-15.4 %)</td></tr><tr><td align="left">Platelets</td><td align="left">242<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">225<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">273<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">382<br/>(Ref Range: 150-450 x10E3/uL)</td><td align="left">297<br/>(Ref Range: 150-450 x10E3/uL)</td></tr><tr><td align="left">Neutrophils</td><td align="left">67<br/>(Ref Range: Not Estab. %)</td><td align="left">68<br/>(Ref Range: Not Estab. %)</td><td align="left">68<br/>(Ref Range: Not Estab. %)</td><td align="left">71<br/>(Ref Range: Not Estab. %)</td><td align="left">64<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Lymphs</td><td align="left">20<br/>(Ref Range: Not Estab. %)</td><td align="left">18<br/>(Ref Range: Not Estab. %)</td><td align="left">21<br/>(Ref Range: Not Estab. %)</td><td align="left">17<br/>(Ref Range: Not Estab. %)</td><td align="left">23<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Monocytes</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">5<br/>(Ref Range: Not Estab. %)</td><td align="left">6<br/>(Ref Range: Not Estab. %)</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">6<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Eos</td><td align="left">4<br/>(Ref Range: Not Estab. %)</td><td align="left">7<br/>(Ref Range: Not Estab. %)</td><td align="left">4<br/>(Ref Range: Not Estab. %)</td><td align="left">3<br/>(Ref Range: Not Estab. %)</td><td align="left">5<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Basos</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Neutrophils (Absolute)</td><td class="bold" align="left">7.2    H<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">6.7<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">5.7<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">5.6<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td><td align="left">6.6<br/>(Ref Range: 1.4-7.0 x10E3/uL)</td></tr><tr><td align="left">Lymphs (Absolute)</td><td align="left">2.1<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.8<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.8<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">1.4<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td><td align="left">2.4<br/>(Ref Range: 0.7-3.1 x10E3/uL)</td></tr><tr><td align="left">Monocytes(Absolute)</td><td align="left">0.7<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.5<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td><td align="left">0.6<br/>(Ref Range: 0.1-0.9 x10E3/uL)</td></tr><tr><td align="left">Eos (Absolute)</td><td align="left">0.4<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td class="bold" align="left">0.7    H<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.4<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td align="left">0.2<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td><td class="bold" align="left">0.5    H<br/>(Ref Range: 0.0-0.4 x10E3/uL)</td></tr><tr><td align="left">Baso (Absolute)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.2 x10E3/uL)</td></tr><tr><td align="left">Immature Granulocytes</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">0<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td><td align="left">1<br/>(Ref Range: Not Estab. %)</td></tr><tr><td align="left">Immature Grans (Abs)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.0<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td><td align="left">0.1<br/>(Ref Range: 0.0-0.1 x10E3/uL)</td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></td></tr><tr><td colspan="4">   <content class="Underline"><span class="bold">Lab:Hgb A1c with eAG Estimation-102525 (Order Date - 06/04/2024) (Collection Date &amp; Time - 06/04/2024 06:43 AM)</span></content></td></tr><tr><td align="left">        </td><td align="left" colspan="2">Value</td><td align="left">Reference Range</td></tr><tr><td align="left">        Hemoglobin A1c</td><td align="left">7.5</td><td align="left">H</td><td align="left">4.8-5.6 - %</td></tr><tr><td align="left">        Estim. Avg Glu (eAG)</td><td align="left">169</td><td align="left"/><td align="left"> - mg/dL</td></tr><tr><td colspan="4"><br/></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content class="bold">Examination: <br/></content>   <span class="Underline">General Examination:</span><br/>      General appearance: alert, pleasant, well-nourished and in no acute distress. <br/>      Heart: regular rate and rhythm without murmurs, gallops, clicks or rubs. <br/>      Lungs: clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes. <br/>      Extremities: normal extremity with no clubbing, cyanosis or edema.    <br/></td></tr><tr><td/></tr></tbody></table></li></ul><br/><content><span class="bold">Assessment:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Assessment: </span></td></tr><tr><td/></tr><tr><td>1. TYPE 2 DIABETES MELLITUS - E11.9 (Primary) 2. S/P total right hip arthroplasty - Z96.641 3. Type 2 diabetes mellitus with other specified complication - E11.69, associated with hyperlipidemia 4. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease - I13.0 5. Mixed hyperlipidemia - E78.2 6. Presence of cardiac pacemaker - Z95.0 7. Sick sinus syndrome - I49.5 8. Chronic systolic CHF (congestive heart failure) - I50.22 9. Long term (current) use of insulin - Z79.4 10. Type 2 diabetes mellitus with diabetic chronic kidney disease - E11.22 </td></tr></tbody></table></li></ul><br/><content><span class="bold">Plan:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Treatment:</span></td></tr><tr><td><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">1. TYPE 2 DIABETES MELLITUS</span> <br/>Notes: Diabetic meds as noted   </td></tr><tr><td/></tr><tr><td><span class="bold">2. S/P total right hip arthroplasty</span> <br/>Notes: Stable   </td></tr><tr><td/></tr><tr><td><span class="bold">3. Type 2 diabetes mellitus with other specified complication</span> <br/>Notes: patient advised to follow lowfat low-cholesterol diet  </td></tr><tr><td/></tr><tr><td><span class="bold">4. Hypertensive heart and chronic kidney disease with heart failure and stage 1 through stage 4 chronic kidney disease, or chronic kidney disease</span> <br/>Continue Lisinopril Tablet, 10 MG, TAKE 1 TABLET TWICE A DAY, Orally, Once a day; Continue Carvedilol Tablet, 12.5 MG, 1 tablet with food, Orally, Twice a day.  </td></tr><tr><td/></tr><tr><td><span class="bold">5. Mixed hyperlipidemia</span> <br/>Continue Atorvastatin Calcium Tablet, 80 MG, 1 tablet, Orally, Once a day; Continue Fenofibrate Tablet, 160 MG, 1 tablet, Orally, Once a day, 90 days, 90 Tablet, Refills 3.  </td></tr><tr><td/></tr><tr><td><span class="bold">6. Presence of cardiac pacemaker</span> <br/>Notes: stable continue follow up with cardiology for pacemaker checks  </td></tr><tr><td/></tr><tr><td><span class="bold">7. Sick sinus syndrome</span> <br/>Notes: stable after pacemaker placement  </td></tr><tr><td/></tr><tr><td><span class="bold">8. Chronic systolic CHF (congestive heart failure)</span> <br/>Continue Furosemide Tablet, 40 MG, TAKE 1 TABLET ONCE DAILY.  </td></tr><tr><td/></tr><tr><td><span class="bold">9. Long term (current) use of insulin</span> <br/>Notes: Stable   </td></tr><tr><td/></tr><tr><td><span class="bold">10. Type 2 diabetes mellitus with diabetic chronic kidney disease</span> <br/>Continue NovoLOG PenFill Solution Cartridge, 100 UNIT/ML, 20 UNITS, Subcutaneous, DAILY BEFORE MEAL; Continue Lantus Solution, 100 UNIT/ML, 40 units, Subcutaneous, daily; Continue metFORMIN HCl Tablet, 500 MG, TAKE 2 TABLETS TWICE A DAY WITH MEALS, Orally, Twice a day.  </td></tr><tr><td/></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Procedure Codes:</span> 1126F AMNT PAIN NOTED NONE PRSNT1159F MED LIST DOCD IN RCRD1160F RVW MEDS BY RX/DR IN RCRD3074F SYST BP LT 130 MM HG3078F DIAST BP &lt; 80 MM HGG8420 BMI&lt;30 AND &gt;=22 CALC &amp; DOCU3288F FALL RISK ASSESSMENT DOCD1101F PT FALLS ASSESS-DOC'D LE1/YRG8427 DOC MEDS VERIFIED W/PT OR RE</td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><span class="bold">Follow Up:</span> 4 Months</td></tr></tbody></table></li></ul><ul><li/></ul><br/><content><span class="bold">Billing  Information:</span></content><br/><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Visit Code:</span></content> <br/>99214 Office Visit, Est Pt., Level 4.  </td></tr></tbody></table></li></ul><ul><li><table width="100%" cellpadding="0" cellspacing="0" border="1"><tbody><tr><td><content><span class="bold">Procedure Codes:</span></content> <br/>1126F AMNT PAIN NOTED NONE PRSNT. <br/>1159F MED LIST DOCD IN RCRD. <br/>1160F RVW MEDS BY RX/DR IN RCRD. <br/>3074F SYST BP LT 130 MM HG. <br/>3078F DIAST BP &lt; 80 MM HG. <br/>G8420 BMI&lt;30 AND &gt;=22 CALC &amp; DOCU. <br/>3288F FALL RISK ASSESSMENT DOCD. <br/>1101F PT FALLS ASSESS-DOC'D LE1/YR. <br/>G8427 DOC MEDS VERIFIED W/PT OR RE. </td></tr></tbody></table></li></ul><br/><tr><td valign="top"><span class="bold">Care Plan Details</span><ul><li><table cellpadding="1" cellspacing="0" border="1"><tbody/></table></li></ul></td></tr><ul><li><table width="100%" border="0"><tbody><tr><td/></tr><tr><td valign="top">Electronically signed by Santiago Morales , MD, ME64207  on 07/15/2024 at 07:31 PM EDT</td></tr><tr><td valign="top">Sign off status: Completed</td></tr><tr><td/></tr></tbody></table></li></ul><span class="content_span">true</span></td></tr></tbody><tbody><tr><td><br/><ul><li><table width="100%" border="0" cellpadding="0" cellspacing="0"><tbody><tr><td align="left"><span class="bold">Provider:</span> Santiago Morales, MD</td><td align="right"><span class="bold">Date: </span>07/10/2024</td></tr><tr><td/><td align="right"><span class="content_span">Generated for Printing/Faxing/eTransmitting on: 09/11/2024 05:57 PM EDT</span></td></tr></tbody></table></li></ul></td></tr></tbody></table></li></ul></div><h3><a name="id10" href="#toc">History and Physical Notes</a></h3><div><ul><li><p>Examination</p><table width="100%" border="1"><colgroup><col width="20%"/><col width="20%"/><col width="40%"/><col width="20%"/></colgroup><thead><tr><th>Category</th><th>Sub-Category</th><th>Detail</th><th>Notes</th></tr></thead><tbody><tr><td rowspan="4">General Examination</td><td>General appearance:</td><td colspan="2">alert, pleasant, well-nourished and in no acute distress</td></tr><tr><td>Heart:</td><td colspan="2">regular rate and rhythm without murmurs, gallops, clicks or rubs</td></tr><tr><td>Lungs:</td><td colspan="2">clear to auscultation bilaterally, with good air movement and no rales, rhonchi or wheezes</td></tr><tr><td>Extremities:</td><td colspan="2">normal extremity with no clubbing, cyanosis or edema</td></tr></tbody></table><br/></li></ul></div><br/><br/></body></html>